39 results
diabetes management comparison diagnosis medications summary inhibitors menstrualcycle ovariancycle table indications insulin oral agonists cardiology classification dm1 glp1 metformin pediatrics
Diabetes Combination Tablets - Estimated A1c Lowering Metformin + DPP4 • Janumet (metformin + sitagliptin) •
Metformin + DPP4 ... dapagliflozin) Dpp4 ... Tablets #Oral #DM2 ... #Pharmacology # ... Pills #Endocrinology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology ... #Inhibitors #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... Inhibitors #Renal #Dosing ... #Pharmacology # ... Management #Diabetes #DM2 ... #Endocrinology
Mechanism of Action for Common Diabetes Medications • SGLT2i (Dapagliflozin) • TZD (Pioglitazone) • Biguanides (Metformin)
Receptor Agonists • DPP4i ... #Medications #pharmacology ... #pathophysiology ... #endocrinology
Profiles of Antidiabetic Medications - AACE 2018 #Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology ... #Pharmacology #
Diabetes Medications Summary Table Insulin Lifestyle modifications Metformin Sulfonylureas GLP-1 receptor agonists - ↓ major adverse CV events TZDs DPP-4 inhibitors SGLT2 inhibitors -
events TZDs DPP ... comparison #management #endocrinology ... #dm2
Stress Dose Steroids - Indications and Dosing SUPPRESSED HPA AXIS: prednisone >20mg/day x 3 weeks or more
Indications and Dosing ... #Indications #Dosing ... #Endocrinology ... Diagnosis #Management #Pharmacology
Stages in the Development of Diabetes Type 1 #Diabetes #Type1 #TypeI #DM1 #Stages #Development #Pathophysiology #Timeline #Diagnosis
#Type1 #TypeI #DM1 ... #Development #Pathophysiology ... Timeline #Diagnosis #Endocrinology
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... mL/minute/1.73 m2 ... #Metformin #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Sulfonylureas - Pharmacology Summary Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... Sulfonylureas #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
No results found for "dosing pharmacology pathophysiology endocrinology dm2 dpp4"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #dosing #pharmacology #pathophysiology #endocrinology #dm2 #dpp4